Your Training Plan Is Smart. Your Genes May Not Be Cooperating.

ACTN3 produces alpha-actinin-3, a structural protein that anchors the contractile machinery inside your fast-twitch muscle fibers. Fast-twitch fibers are the ones that fire during explosive movements, sprints, heavy lifts, and max-effort efforts. They’re the reason some people are naturally explosive and powerful. Without functional ACTN3, your fast-twitch fibers lack this structural scaffolding.

Roughly 18% of people of European ancestry carry the X/X genotype, meaning they have two nonfunctional copies of ACTN3. When you have the X/X variant, your fast-twitch fibers never fully develop the structural capacity for explosive power generation. You literally can’t recruit and coordinate these fibers the way people with at least one functional copy can.

This shows up as a plateau in your power output, sprint speed, and maximum strength even with months of training. Explosive training feels harder. You never quite achieve the peak power your training program assumes. If your goals are strength and muscle size (which require explosive intent during lifts), this variant is a real ceiling.

PPARGC1A produces PGC-1 alpha, the master switch that tells your cells to build new mitochondria in response to training. Mitochondria are the power plants of your muscles. More mitochondria means better oxygen utilization, higher VO2max potential, and superior endurance capacity. When you do cardio or sustained effort training, your body should be building dozens of new mitochondria in each muscle cell. That process is controlled by PGC-1 alpha.

The Ser variant of PPARGC1A, carried by roughly 35-40% of people, reduces your mitochondrial biogenesis response to exercise by 20-30%. You can do the same cardio workouts as someone with the Gly variant, but your cells are building fewer new mitochondria and thus not adapting as robustly. Your aerobic capacity, endurance, and training-induced metabolic adaptations all lag behind what your training volume should produce.

You might notice this as a plateau in your aerobic fitness despite weeks of cardio work. Your VO2max doesn’t climb the way you’d expect. You stay winded on efforts that should feel more comfortable. Recovery after conditioning workouts feels slower. You’re doing the work, but your engine isn’t getting bigger.

ADRB2 produces the beta-2 adrenergic receptor, which sits on the surface of your fat cells and listens for the signal to release stored energy. When you exercise, your nervous system releases epinephrine and norepinephrine (catecholamines). These bind to the beta-2 receptor and trigger lipolysis, the breakdown and mobilization of fat. Without this signaling, your fat cells stay locked down even in a caloric deficit.

The Gln27Glu and Arg16Gly variants in ADRB2, present in roughly 40% of the population, reduce your fat cells’ sensitivity to catecholamine signaling by 20-50%. Your fat cells simply don’t respond as robustly to the hormonal signal to release energy. You can do the same cardio, create the same caloric deficit, and your body mobilizes significantly less fat than someone with the wild-type variant.

This manifests as stubborn body composition. You diet hard. You train consistently. The scale moves, but your fat loss is slower and more difficult than it should be. Body recomposition feels frustratingly slow. You see less progress in mirror changes despite putting in the same effort as peers.

VDR produces the vitamin D receptor, the cellular antenna that receives the vitamin D signal and triggers muscle protein synthesis, calcium signaling, and the inflammatory resolution needed after training. Vitamin D isn’t just a vitamin; it’s a hormone that controls whether your muscles can actually build back bigger after you damage them with training. Your muscles are built during recovery, not during the workout itself. VDR is the gatekeeper of that process.

VDR variants, present in roughly 30-50% of people depending on the specific polymorphism, impair your muscles’ ability to respond to vitamin D signaling and mount an effective protein synthesis response after training. Even if your vitamin D levels are normal, your muscle cells simply can’t use it as effectively. Your recovery stalls. Adaptation slows. Muscle soreness lingers longer.

You feel this as chronic soreness that doesn’t resolve between sessions, slower strength progression, and a sense that each workout is leaving you beat up for longer than it should. You might have normal vitamin D blood levels but your muscles are still functionally vitamin D deficient at the cellular level.

SOD2 produces superoxide dismutase 2, the antioxidant enzyme that lives inside your mitochondria and neutralizes free radicals created during energy production. When you exercise, you generate reactive oxygen species (free radicals) as a byproduct of burning fuel. Some oxidative stress is actually the stimulus for adaptation. But too much overwhelms your muscles’ repair capacity and extends recovery time.

The Val16Ala variant in SOD2, homozygous in roughly 40% of the population, reduces your mitochondrial antioxidant capacity by 20-30%, meaning your muscles accumulate oxidative damage faster during exercise. You get more free radicals per training session than someone with the Ala variant. Your muscles spend more energy on damage control and less on adaptation. Recovery is measurably slower. Delayed-onset muscle soreness (DOMS) is more pronounced and longer-lasting.

You’ll notice this as excessive soreness after workouts, a sense that you can’t recover in time for your next session, and feeling beat up despite reasonable training volume. You might also experience more fatigue during high-volume training blocks.

MTHFR produces methylenetetrahydrofolate reductase, an enzyme that converts dietary folate into the active form your cells use to manage homocysteine and produce red blood cells. Homocysteine is a metabolic waste product. At high levels, it damages blood vessel walls and reduces nitric oxide production, the molecule that keeps your arteries elastic and allows them to dilate during exercise.

The C677T variant in MTHFR, carried by roughly 40% of people of European ancestry, reduces enzyme efficiency by 40-70%, causing homocysteine to accumulate and impairing your blood vessels’ ability to dilate and deliver oxygen during training. Your aerobic capacity ceiling is artificially lowered. Your muscles aren’t getting enough oxygen per unit of effort. Every cardio session feels harder than it should.

You experience this as poor aerobic capacity, premature fatigue during conditioning work, and a sense that your cardiovascular fitness isn’t improving despite months of training. Your VO2max plateau feels stubborn. Recovery between intervals is slower.